New treatment insights into pancreatic acinar cell carcinoma: case report and literature review
Fangrui Zhao, Dashuai Yang, Tangpeng Xu, Jiahui He, Jin Guo, Xiangpan Li
Abstract
Pancreatic acinar cell carcinoma (PACC) is a rare pancreatic malignancy with unique clinical, molecular, and morphologic features. The long-term survival of patients with PACC is substantially better than that of patients with ductal adenocarcinoma of the pancreas. Surgical resection is considered the first choice for treatment; however, there is no standard treatment option for patients with inoperable disease. The patient with metastatic PACC reported herein survived for more than 5 years with various treatments including chemotherapy, radiotherapy, antiangiogenic therapy and combined immunotherapy.
Topics & Concepts
MedicineMalignancyChemotherapyImmunotherapyRadiation therapyPancreasAdenocarcinomaOncologyDiseaseCarcinomaPancreatic ductal adenocarcinomaInternal medicinePathologyPancreatic cancerCancerPancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics